CVS Health shows prevailing Real Value of $82.0988 per share. The current price of the firm is $72.88. At this time the firm appears to be under valued. Macroaxis approximates value of CVS Health from analyzing the firm fundamentals such as Return On Equity of 8.71% and Profit Margin of 1.65% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point future time assets prices and their ongoing real values will blend.
CVS Health Corporation is rated third in market capitalization category among related companies. Market capitalization of Health Care Plans industry is currently estimated at about 537.98 Billion. CVS Health retains roughly 99.02 Billion in market capitalization claiming about 18% of equities under Health Care Plans industry.
CVS Health Corporation is rated below average in price to earning category among related companies. It is rated below average in beta category among related companies totaling about 0.04 of Beta per Price to Earning. The ratio of Price to Earning to Beta for CVS Health Corporation is roughly 25.18
CVS Health is not too risky asset. Calculation of real value of CVS Health is based on 2 months time horizon. Increasing CVS Health time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.